A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia. [electronic resource]
Producer: 20170726Description: 1493-501 p. digitalISSN:- 1476-5551
- Apoptosis -- drug effects
- Cell Proliferation -- drug effects
- Dasatinib -- pharmacology
- Drug Resistance, Neoplasm
- Drug Tolerance
- Forkhead Box Protein O1 -- analysis
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Humans
- Imatinib Mesylate -- pharmacology
- Indazoles -- pharmacology
- K562 Cells
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Sulfonamides -- pharmacology
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.